Research Article

In Silico Approach Triterpene Glycoside of H. atra Targeting Orotidine 5-Monophosphate Decarboxylase Protein (PfOMPDC) in P. falciparum Infection Mechanism

Table 3

Compounds, hydrogen bonds, hydrophobic interaction, unfavorable, and electrostatic interaction of ligand–protein complexes.

CompoundsHydrogen bondHydrophobicUnfavorableElectrostatic

Holothurin A1PRO110 (3.03); TYR111 (3.04); TYR156 (2.07); TYR111 (2.0); TYR156 (2.0); GLU77 (2.7; 2.9; 3.0);LYS151 (4.5); ILE29 (4.9); PHE79 (3.85)GLU30 (1.8; 1.5; 1.6); SER76 (1.7; 1.9; 0.7; 1.5); SER113 (2.6)
Holothurin A3ARG150 (2.6; 2.3; 2.38; 2.7), GLU30 (2.5; 2.1), ASP179 (2.05), GLU30 (2.18), GLU155 (2.7), GLU181 (1.6), LYS147 (1.75)ILE29 (4.2), PHE79 (2.88)GLU155 (2.1; 1.3); GLU26 (1.7); GLU30 (2.6)
Holothurin BSER57 (2.57); TYR156 (3.04); SER76 (2.12); GLU26 (1.83)VAL114 (4.4); PHE79 (5.0; 4.6; 4.07); TYR111 (4.05; 2.24)ASN144 (2.2; 1.4); LYS147 (2.1; 2.0; 2.6); TYR156 (0.89); GLU30 (1.57; 1.55)ASP175 (3.06)
Echinoside ATYR156 (5.4); PHE79 (4.4; 4.5); TYR111 (4.6)ASN183 (1.7; 1.6; 2.1; 1.9); LYS184 (2.6); GLU26 (1.6; 1.5); PHE79 (1.8; 1.9); TYR111 (2.1; 1.8; 1.6; 1.2; 1.3)
Echinoside BGLU26 (2.2; 1.2; 2.0; 1.1); TYR111 (2.0)ASP61 (3.5)
17-Hydroxyfuscocineroside BSER76 (2.4); TYR156 (2.2); TYR111 (2.7; 2.0); ASP117 (2.0); SER113 (1.9)LYS151 (5.0); TYR111 (5.1)ASP117 (2.1; 1.7; 1.8; 2.04); LYS151 (2.2; 1.7); ASP175 (2.4; 1.9); ILE176 (2.6); SER76 (2.3; 2.2; 2.2; 1.2; 1.2); SER113 (2.1; 1.4; 1.8; 1.4)ASP175 (4.2); LYS174 (3.0); TYR178 (2.2)
24-Dehydroechinoside BSER113 (2.5; 2.6); TYR111 (2.7); GLU26 (2.2; 2.7)LYS27 (5.0)GLU30 (2.2); TYR111 (1.8; 2.1; 0.8)GLU77 (3.3)
Fuscocineroside CLYS27 (2.7); GLU30 (2.6); GLU26 (2.08; 2.1); GLU78 (2.3)LYS151 (5.3; 4.1)ASP141 (2.7; 1.6; 2.7); LYS151 (2.2; 1.1; 1.5); GLU26 (2.0; 1.3); TYR111 (2.3; 1.8; 1.8)ASP141 (3.4), PHE79 (3.82)
Calcigeroside BLYS27 (2.3); GLU26 (2.4; 1.9;); GLU30 (3.08); GLU155 (2.7)GLU155 (1.9; 1.99; 1.3; 1.14)